Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-04 |
filingDate |
2015-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7512b31fe5fec6755ef38c82c15d211b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_061c378d5f76153252174e78f822afb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4616fe132c787c469b5499895ca060de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c12301f155262f8ebe391455bb9f51b |
publicationDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9346763-B2 |
titleOfInvention |
Process for the preparation of pyrazole carboxylic acid derivatives |
abstract |
The present invention relates to a novel process for the preparation of a pyrazole carboxylic acid derivative of the formula n n n n n n n n n n n n wherein R 1 is C 1-7 -alkyl and R 3 is C 1-7 -alkyl which is optionally substituted with halogen or C 1-4 -alkoxy. The pyrazole carboxylic acid derivative of the formula I can be used as building block in the preparation of pharmaceutically active principles e.g. for compounds acting as phosphodiesterase (PDE) inhibitors, particularly PDE10 inhibitors. PDE10 inhibitors have the potential to treat psychotic disorders like schizophrenia. |
priorityDate |
2012-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |